Nasal inoculation of the commensal neisseria lactamica inhibits carriage of neisseria meningitidis by young adults: A controlled human infection study

Clinical Infectious Diseases

Volumn 60, Issue 10, 2015, Pages 1512-1520

  Deasy, Alice M ^a   Guccione, Ed ^a   Dale, Adam P ^b   Andrews, Nick ^c   Evans, Cariad M ^a   Bennett, Julia S ^d   Bratcher, Holly B ^d   Maiden, Martin C J ^d   Gorringe, Andrew R ^c   Read, Robert C ^b  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

herd protection; meningococcal carriage; meningococcal vaccination; Neisseria lactamica; Neisseria meningitidis

Indexed keywords

LIVE VACCINE; MENINGOCOCCUS VACCINE; PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; GENE SEQUENCE; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; MALE; MENINGOCOCCOSIS; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROAT CULTURE; VACCINATION; YOUNG ADULT; ADOLESCENT; ANTIBIOSIS; GROWTH, DEVELOPMENT AND AGING; HETEROZYGOTE; ISOLATION AND PURIFICATION; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; PREVENTION AND CONTROL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBIOSIS; CARRIER STATE; FEMALE; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; PROBIOTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929179287     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ098     Document Type: Article

References (27)

1. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-Analysis. Lancet Infect Dis 2010; 10:853-61.
2. Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C. Global epidemiology of invasive meningococcal disease. Popul Health Metr 2013; 11:17.
3. Maiden MC, Ibarz-Pavón AB, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 2008; 197:737-43.
4. Trotter CL, McVernon J, Ramsay ME, et al. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008; 26:4434-45.
5. Vesikari T, Esposito S, Prymula R, et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet 2013; 381:825-35.
6. Read RC, Baxter D, Chadwick DR, et al. Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet 2014; 384:2123-31.
7. Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978; 137:112-21.
8. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99:591-601.
9. Olsen S, Djurhuus B. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 1991; 106:445-57.
10. Coen P. Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica. Int J Epidemiol 2000; 29:180-8.
11. Trotter C, Findlow J, Balmer P, Holland A. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England. Clin Vaccin Immunol 2007; 14: 863-8.
12. Evans CM, Pratt CB, Matheson M, et al. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis 2011; 52:70-7.
13. Jolley KA, Maiden MCJ. AgdbNet-Antigen sequence database software for bacterial typing. BMC Bioinformatics 2006; 7:314.
14. Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595.
15. Trotter CL, Maiden MCJ. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 2009; 8:851-61.
16. Wong HEE, Li M-S, Kroll JS, Hibberd ML, Langford PR. Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica. PLoS One 2011; 6:e26130.
17. Kremastinou J, Tzanakaki G, Levidiotou S, et al. Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece. Fems Immunol Med Mic 2003; 39:23-9.
18. Simmons G, Martin D, Stewart J, Bremner D. Carriage of N. lactamica in a population at high risk of meningococcal disease. Epidemiol Infect 2000; 125:99-104.
19. Vaughan AT, Gorringe A, Davenport V, Williams NA, Heyderman RS. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage. J Immunol 2009; 182:2231-40.
20. Andrade JRC, Marques MDC, de Santa Rosa MR. Nasal secretions of Neisseria lactamica carriers have an inhibitory effect on Neisseria meningitidis attachment to human oroepithelial cells. Mem Inst Oswaldo Cruz 1986; 81:453-7.
21. Ala'Aldeen DA, Neal KR, Ait-Tahar K, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 2000; 38:2311-6.
22. Ala'Aldeen DAA, Oldfield NJ, Bidmos FA, et al. Carriage of meningococci by university students, United Kingdom. Emerging Infect Dis 2011; 17:1762-3.
23. MacLennan J, Kafatos G, Neal K, et al. Social behavior and meningococcal carriage in British teenagers. Emerging Infect Dis 2006; 12:950-7.
24. Lee C-C, Middaugh NA, Howie SRC, Ezzati M. Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage: a systematic review and meta-Analysis. PLoS Med 2010; 7:e1000374.
25. Roos K, Håkansson EG, Holm S. Effect of recolonisation with "interfering" alpha streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 2001; 322:210-2.
26. Skovbjerg S, Roos K, Holm SE, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child 2009; 94:92-8.
27. Glü ck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003; 77:517-20.